InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 18.69
-0.81 (-4.15%)
At close: Jun 1, 2026
InventisBio Market Cap
InventisBio has a market cap or net worth of 10.81 billion as of June 1, 2026. Its market cap has decreased by -12.74% in one year.
Market Cap
10.81B
Enterprise Value
9.45B
Revenue
71.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.69
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 10.81B, an increase of 22.95%. That is a compound annual growth rate of 5.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 11.28B | -28.41% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mabwell (Shanghai) Bioscience | 13.04B |
| Jinyu Bio-technology | 12.75B |
| Staidson (Beijing) BioPharmaceuticals | 12.32B |
| Pacific Shuanglin Bio-pharmacy | 12.26B |
| Tibet Cheezheng Tibetan Medicine | 11.93B |
| HitGen | 11.84B |
| Inner Mongolia Furui Medical Science | 11.83B |
| Chengzhi | 11.64B |